SR419
SR419-102
Phase 2 small_molecule completed
Quick answer
SR419 for Peripheral Neuropathic Pain is a Phase 2 program (small_molecule) at Shanghai University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shanghai University of Traditional Chinese Medicine
- Indication
- Peripheral Neuropathic Pain
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed